Cath Lab Digest - February 2008 - (Page 65)

Achieving Optimal Outcomes in Carotid Stenting: Lessons Learned from Recent Clinical Trials Complimentary Accredited On-Demand Webcast Presenter William A. Gray, MD Director, Endovascular Services Center for Interventional Vascular Therapy Columbia University Medical Center New York, NY This activity is supported by an educational grant from Abbott Vascular. Target Audience: Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Neurologists, Interventional Nurses and Technologists. Viewing On-Demand Webcast: Please visit www.naccme.com. For questions, please call 800-237-7285, ext. 202. Accreditation: MD/DO: This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies. Nurses:ANCC: NACCME is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour. Provider #: 110-3-E-06. Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 1 contact hour. Technologists: SICP Approved for 1 credit hour. Sponsor: North American Center for Continuing Medical Education Faculty Disclosures: All those with control over the content of continuing education programs sponsored by NACCME are expected to disclose to the meeting audience any real or apparent conflicts of interest related to the content of their presentations. It is not assumed that these financial interests or affiliations will have an adverse impact on presentations; they are simply noted here to fully inform participants. Dr. Gray has disclosed that he is a consultant to Abbott Vascular, Access Closure, Inc., CoAptus Medical Corporation, Mercator MedSystems, Inc., Sage Medical, Inc., Ovalis, Inc., Paragon IP, and Pathway Medical Technologies. He is a major shareholder/options holder in Access Closure, Inc., CoAptus Medical Corporation, Sage Medical, Inc., Ovalis Inc, Paragon IP, and Pathway Medical Technologies. http://www.naccme.com

Table of Contents Feed for the Digital Edition of Cath Lab Digest - February 2008

Cath Lab Digest - February 2008 Bay Regional Medical Center ENDEAVOR IV: A Zotarolimus-Eluting Stent Versus a Paclitaxel-Eluting Stent in a Randomized Clinical Trial A 3D CT Vessel “Roadmap” Over Live Fluoroscopy for Chronic Total Occlusions Contents Clinical Editor’s Corner An Evaluation of Cath Lab Turnaround Time Commentary: An Evaluation of Cath Lab Turnaround Time Excerpts from Chapter 19. STEMI Interventions – Future Perspectives The Potential Clinical Utility of Intravascular Ultrasound Guidance in Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents The Ten-Minute Interview with…Debbie Charlton, RN The Society of Invasive Cardiovascular Professionals (SICP) at Transcatheter Cardiovascular Therapeutics (TCT) 2007 The Cath Lab is a Business: Do You Have the Knowledge to Stay Afloat? Incidence and Predictors of Vascular Complications after Invasive Coronary Procedures: A Prospective Analysis Ask the Clinical Instructor: A Q&A Column for those New to the Cath Lab Volunteer Survey SICP* Section Meetings Calendar What Do You Think? CEU Education Center Clinical & Industry News Classifieds Advertisers Index

Cath Lab Digest - February 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.